American HealthCare Capital is pleased to introduce a multi-location, retail, specialty, and compounding pharmacy for sale in the Austin, Texas area. The company has been in business for 9 years. They focus on a wide range of therapies, including hormone replacement, pain management, wound and scar care, sports medicine, dermatology, pediatrics, dentistry, veterinary, erectile dysfunction, palliative care, anti-aging along with nutritional supplements. One of the locations includes both negative and positive ISO class 7 modular clean rooms.
Approximately 91% of their business is walk in and delivery, and 9% of their business is mail order. In 2017, gross revenues were $8.8 Million with an Adjusted EBITDA of $754,424. In the first six months of 2018, the revenues were $5,511,436 with an Adjusted EBITDA of $2,217,339, and the expected run rate is $11 Million or higher. The adjusted EBITDA margin is expected to be in the same range or even higher as a result of specific new marketing initiatives based upon product diversification, as well as management style and labor cost initiatives.
Each location is fully staffed, and employees are expected to continue working under new ownership. The asking price is $12 Million. The seller is willing to sell a majority percentage of the company on a pro rata basis and participate fully in a joint venture wherein he provides ongoing, value-added support to the business.
If you would like to learn more, please contact us for a Confidentiality Agreement that will allow us to share more detailed information with you.